NDC 55346-0942-01: Alpha-Pro Sodium Fluoride and Hydrofluoric Acid 7.9 mg/g; 4.4 mg/g Gel, 497 g Bottle
This is a package of 497 g of Alpha-Pro Sodium Fluoride and Hydrofluoric Acid 7.9 mg/g; 4.4 mg/g Gel from Dental Technologies, Inc., first listed with the FDA Apr 2013 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 55346-0942-1 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 55346 labeler · 0942 product · 1 package
- Package marketed since
- Apr 1, 2013
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 5534609421 4
- FDA record last changed
- Nov 19, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 1297381
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
RxNorm drug class
This medicine belongs to the Caries prophylactic agents class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Nov 19, 2026
Clinical
Alpha-Pro is a dental gel containing sodium fluoride and hydrofluoric acid. Both ingredients are typically used in dental products to help strengthen tooth enamel and reduce tooth sensitivity. This product is an unapproved drug and is not marketed under an FDA-approved application. It is applied directly to the teeth by a dental professional.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 55346-0942-01 You're viewing this Main listing | 497 g in 1 BOTTLE | 2013-04-01 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Alpha-Pro 7.9 mg/g; 4.4 mg/gthis 55346-0942-01 | Dental | 497 g | — | — | FDA listed | — |
| Alpha-Pro 7.9 mg/g; 4.4 mg/g 55346-0943-01 | Dental | 497 g | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
What it looks like
Where does this data come from?
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Dental Technologies, Inc. labeler code 55346
- Home Care Fluoride Stannous .969 mg/g Gel NDC 55346-0401-1
- Home Care Fluoride Stannous .969 mg/g Gel NDC 55346-0402-1
- Home Care Fluoride Stannous .969 mg/g Gel NDC 55346-0404-1
- Home Care Fluoride Stannous .969 mg/g Gel NDC 55346-0408-1
- Alpha-Pro Sodium Fluoride and Hydrofluoric Acid 7.9 mg/g; 4.4 mg/g Gel NDC 55346-0943-1
- Alpha-Caine Topical Anesthetic Benzocaine 200 mg/g Gel NDC 55346-2901-1
- Alpha-Caine Topical Anesthetic Benzocaine 200 mg/g Gel NDC 55346-2902-1
- Alpha-Caine Topical Anesthetic Benzocaine 200 mg/g Gel NDC 55346-2903-1
- Alpha-Caine Topical Anesthetic Benzocaine 200 mg/g Gel NDC 55346-2904-1
- San-EZ Hand Sanitizer Ethyl Alcohol 70% 70 mL/100mL Gel NDC 55346-3302-1
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full prescribing information FDA SPL
🎯 Indications and Usage ▾
Indications and Usage: Topical application of APF gel is indicated in the prevention of dental caries. This treatment is normally used two times per year and should not exceed four times a year.
⏱️ Dosage and Administration ▾
Dosage and Administration: After thorough prophylaxis, place gel in applicator tray (not more than 1/3 full). Throughly air-dry teeth and insert tray(s) in mouth. Gel may also be swab applied. Instruct patient to bite down slightly but firmly for one to four minutes. A slight chewing motion enhances coverage interproximally. Remove tray(s) and have patient expectorate excess gel. Instruct patient not to eat, drink or rinse for at least 30 minutes.
⛔ Contraindications ▾
Contraindications: Hypersensitivity to fluoride.
⚠️ Warnings ▾
Warning: Keep out of reach of children. Do not swallow. If swallowed during treatment, administer milk, limewater, or antacid. If larger dose is ingested (more than 1/4 ounce), contact poison control and immediately seek medical help. Contains FD&C Red No. 40.
🤒 Adverse Reactions ▾
Adverse Reactions: Developing teeth of children under age 6 may become permanently discolored if excessive amounts are repeatedly swallowed. The following adverse reactions are possible in individuals hypersensitive to fluoride: eczema, atopic dermatitis, urticaria, gastric distress, headache, and weakness.
📦 How Supplied / Storage and Handling ▾
How Supplied: A gel, one bottle contains up to 68 individual applications. Store at controlled room temperature 20°- 25°C (68°-77°F). Do not allow to freeze.
📋 Description ▾
Active Ingredients: 1.23% w/w Fluoride Ion (0.79% from Sodium Fluoride and 0.44% from Hydrogen Fluoirde) in
0.1Molar Phosphoric Acid. DENTAL TECHNOLOGIES LINCOLNWOOD, ILLINOIS 60712 USA www.dentaltech.com Questions or Comments? Call: 1-800-835-0885 (US) or 1-847-677-5500 PM-5097 Rev002
⚠️ Precautions ▾
Precautions: For professional use only. This product is not intended for home or unsupervised consumer use. Repeated use may cause dulling of porcelain and ceramic restorations.
📄 Package Label / Principal Display Panel ▾
Principal Display Panel DENTAL TECHNOLOGIES www.dentaltech.com ALPHA-PRO® APF TOPICAL GEL 60 SECOND TREATMENT Acidulated Phosphate Fluoride 1.23% Fluoride Ion Rx Only Strawberry REF No. 009-4201-002 NET WEIGHT: 17.5 oz. (497g) APF_Strawberry
About this NDC listing & data coverage
Listed without an FDA application
This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |